Outcomes

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.

Outcomes

Trevigen acquired by Bio-Techne September 5, 2017

Crosstree Capital Partners acted as exclusive financial advisor to Trevigen.

Outcomes

OmniSeq Received a Strategic Investment from LabCorp August 21, 2017

Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq Inc.

Outcomes

Access Regional Laboratory Business acquired by LabCorp June, 2017

Crosstree Capital Partners acted as exclusive financial advisor to Access.

Outcomes

IDT acquired the Oligo Manufacturing Business of GeneWorks February 8, 2017

Crosstree Capital Partners initiated this transaction on behalf of IDT.

Outcomes

Tulip Group acquired by PerkinElmer January 9, 2017

Financial advisor to Tulip Group.

Outcomes

Mo Bio acquired by Qiagen January 11, 2016

Crosstree Capital Partners acted as exclusive financial advisor to MO BIO.

Outcomes

Cliniqa acquired by Bio-Techne July 9, 2015

Crosstree Capital Partners served as exclusive financial advisor to Cliniqa Corporation.

Outcomes

Converge acquired by Quest Diagnostics October 7, 2013

Crosstree Capital Partners served as exclusive financial advisor to Water Street and ConVerge.

Outcomes

Critical Path Service Acquired by Knoell June 13, 2013

Crosstree Capital Partners served as exclusive financial advisor to CPS.